Dr. Talal Hilal
Mayo Clinic Arizona
Dr. Talal Hilal, a Phoenix-based hematologist with Mayo Clinic Arizona, explains to SurvivorNet how BTK inhibitors work as a first-line treatment for chronic lymphocytic leukemia (CLL) patients.
Dr. Talal Hilal
Mayo Clinic Arizona
Learn how combination therapy with BTK inhibitors and venetoclax treats chronic lymphocytic leukemia (CLL), including the benefits, potential side effects, and how it compares with continuous BTK inhibitor therapy.
